Status: Not yet recruiting
Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction
A prospective ,multiple center Study about the Safety and Efficacy of the Thoracic Aortic Multi-Branch Stent Graft System, developed and manufactured by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., in patients with aortic arch pathologies.
Participants needed: 96
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Shanghai MicroPort Endovascular MedTech（Group）Co., LtdUpdated: Aug 24, 2025Locations: 1
Eligibility criteria
Aged 18 to 80 years [+3]
Pregnant or lactating women [+15]